Pharmaceutical Commerce Magazine

09/12/2024

The parties’ want to provide customers with a “one-stop-shop,” with the hopes that their services will be easier to navigate.

09/12/2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

09/11/2024

A pooled analysis of the SWIFT-1 and SWIFT-2 trials found 54% reduction in exacerbation rates over 52 weeks in patients with severe asthma with type 2 inflammation treated with depemokimab.

09/11/2024

The latest news for pharma industry insiders.

09/10/2024

The latest news for pharma industry insiders.

09/09/2024

The latest news for pharma industry insiders.

09/05/2024

📍 Coverage from
Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

09/05/2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

09/04/2024

The latest news for pharma industry insiders.

09/03/2024

How can industry stakeholders ensure the quality and supply chain security of existing product?🖋️ Dan Bell, Senior Vice President, Innovation & Strategic Operations, Marken

How can industry stakeholders ensure the quality and supply chain security of existing product?

09/03/2024

The latest news for pharma industry insiders.

08/30/2024

📍 Coverage from
Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.

Moderator: Ilisa Bernstein, president of Bernstein Rx Solutions, LLC

Panelists: Jennell Bilek, equity partner, Carlson Caspers; Chris Smith, senior counsel, Epstein Becker & Green, P.C.; and Theodore Sullivan, partner, Quarles & Brady LLP

Panel offers suggestions on how compliance teams should be considering handling SOPs, stabilization, and much more.

08/30/2024

The latest news for pharma industry insiders.

08/29/2024

📍 Coverage from
Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall

“Filing WEEs: Lessons Learned HDA Perspectives on DSCSA Implementation and Readiness,” featuring Elizabeth Gallenagh, general counsel and SVP, supply chain integrity, HDA - Healthcare Distribution Alliance; Tish Pahl, principal, Olsson Frank Weeda Terman Matz PC; and Brian Waldman, partner, ArentFox Schiff LLP

Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain.

08/29/2024

The latest news for pharma industry insiders.

08/28/2024

The latest news for pharma industry insiders.

08/28/2024

📍 Coverage from
Day 1 of this year’s HDA - Healthcare Distribution Alliance’s Traceability Seminar started off with arguably one of the more anticipated sessions of the conference, being that it featured the FDA, who authored the Drug Supply Chain Security Act ( )

The presentation, titled “State of Implementation: FDA’s Perspective,” was led by both Leigh Verbois, director of the office of drug security, integrity, and response (ODSIR) within CDER’s office of compliance, and Abha Kundi, JD, MPH, team lead

The agency provides an update surrounding the Act’s implementation efforts.

08/27/2024

The latest news for pharma industry insiders.